Hailed as a savior, Dr. Thomas C. Weiner became a patient favorite and his hospital’s highest earner. As the myth surrounding him grew, so did the trail of patient harm.

60 Degrees Pharmaceuticals has found that the total cumulative accessible market through the end of U.S. patent protection in December, 2035 for ARAKODA ® ( tafenoquine) for babesiosis may exceed ...